Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.
Clin J Oncol Nurs
; 12(3 Suppl): 9-12, 2008 Jun.
Article
en En
| MEDLINE
| ID: mdl-18490252
ABSTRACT
Nurses play an essential role in managing the care of patients with multiple myeloma, who require education and support to receive and adhere to optimal therapy. The International Myeloma Foundation created a Nurse Leadership Board comprised of oncology nurses from leading cancer centers and community practices. An assessment survey identified the need for specific recommendations for managing key side effects of novel antimyeloma agents. Myelosuppression, thromboembolic events, peripheral neuropathy, steroid toxicities, and gastrointestinal side effects were selected for the first consensus statements. The board developed recommendations for healthcare providers in any medical setting, including grading of side-effect toxicity and strategies for managing the side effects in general, with specific recommendations pertaining to the novel agents.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Sociedades de Enfermería
/
Consenso
/
Liderazgo
/
Mieloma Múltiple
/
Antineoplásicos
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Clin J Oncol Nurs
Asunto de la revista:
ENFERMAGEM
/
NEOPLASIAS
Año:
2008
Tipo del documento:
Article
País de afiliación:
Estados Unidos